Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14
Phase 23

Trial Status

Completed3
Recruiting1
Terminated2
Other1

Role Distribution

Principal Investigator6
Other Roles1
PI Rate86%

Activity Timeline

Clinical Trials (7)

NCT06450925Phase 2Recruiting
Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
Graft Vs Host DiseaseVitamin A DeficiencyVitamin D Deficiency
PrincipalinvestigatorStart date: 2025-03-25
NCT06695507Phase 1Terminated
Upfront Ruxolitinib for Chronic Graft-vs-host Disease
Chronic Graft Versus Host Disease
PrincipalinvestigatorStart date: 2025-02-19
NCT05121142Phase 1Completed
Study of Ruxolitinib for Acute and Chronic Graft Versus Host Disease
Acute-graft-versus-host DiseaseChronic Graft-versus-host-diseaseSolid Organ Transplant
PrincipalinvestigatorStart date: 2021-10-27
NCT04263597Phase 1/2Completed
Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipients
Hematopoietic Stem Cell Transplant
PrincipalinvestigatorStart date: 2020-08-26
NCT02167451Phase 1/2Terminated
Maraviroc as GVHD Prophylaxis in Transplant Recipients
Diagnoses That Require Stem Cell TransplantGraft Versus Host Disease (GVHD)
Principalinvestigator
NCT02511782Not ApplicableCompleted
Transdermal Patch to Monitor Inflammatory Biomarkers of GVHD
Graft Versus Host Disease
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT06450925Phase 2PrincipalInvestigator

Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.

Graft Vs Host DiseaseVitamin A DeficiencyVitamin D Deficiency
Recruiting
NCT06695507Phase 1PrincipalInvestigator

Upfront Ruxolitinib for Chronic Graft-vs-host Disease

Chronic Graft Versus Host Disease
Terminated
NCT05121142Phase 1PrincipalInvestigator

Study of Ruxolitinib for Acute and Chronic Graft Versus Host Disease

Acute-graft-versus-host DiseaseChronic Graft-versus-host-diseaseSolid Organ Transplant
Completed
NCT04263597Phase 1/2PrincipalInvestigator

Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipients

Hematopoietic Stem Cell Transplant
Completed
NCT02167451Phase 1/2PrincipalInvestigator

Maraviroc as GVHD Prophylaxis in Transplant Recipients

Diagnoses That Require Stem Cell TransplantGraft Versus Host Disease (GVHD)
Terminated
NCT02511782Not ApplicablePrincipalInvestigator

Transdermal Patch to Monitor Inflammatory Biomarkers of GVHD

Graft Versus Host Disease
Completed
NCT05722912StudyDirector

Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD

Graft-versus-host Disease (GVHD)
Unknown

All 7 trials loaded